Beta 2 adrenergic receptor agonists as a treatment for metabolic dysfunction-associated steatohepatitis (MASH).
Saved in:
| Title: | Beta 2 adrenergic receptor agonists as a treatment for metabolic dysfunction-associated steatohepatitis (MASH). |
|---|---|
| Authors: | Winkler BS; Department of Medicine, Medical University of South Carolina, Charleston, SC, USA., Stayer KM; Department of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, SC, USA., Rao AK; Department of Medicine, Medical University of South Carolina, Charleston, SC, USA., Arif E; Department of Medicine, Medical University of South Carolina, Charleston, SC, USA., Mendenhall TT; Department of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, SC, USA., Thomas KL; Department of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, SC, USA., Driggers KR; Department of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, SC, USA., Zuo X; Department of Medicine, Medical University of South Carolina, Charleston, SC, USA., Fitzgibbon W; Department of Medicine, Medical University of South Carolina, Charleston, SC, USA., Deng P; Department of Medicine, Medical University of South Carolina, Charleston, SC, USA., Su Y; Department of Medicine, Medical University of South Carolina, Charleston, SC, USA., Dang Y; Department of Medicine, Medical University of South Carolina, Charleston, SC, USA., Gerges M; Department of Medicine, Medical University of South Carolina, Charleston, SC, USA., Kagan D; Department of Medicine, Medical University of South Carolina, Charleston, SC, USA., Pasham V; Department of Pathology, Medical University of South Carolina, Charleston, SC, USA., Wolf B; Department of Public Health Sciences, Medical University of South Carolina, Charleston, SC, USA., Rockey DC; Department of Medicine, Medical University of South Carolina, Charleston, SC, USA.; Department of Medicine, Ralph H. Johnson Veterans Affairs Medical Center, Charleston, SC, USA.; Digestive Disease Research Center, Medical University of South Carolina, Charleston, SC, USA., Hartman JH; Department of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, SC, USA., Lipschutz JH; Department of Medicine, Medical University of South Carolina, Charleston, SC, USA. Lipschut@musc.edu.; Department of Medicine, Ralph H. Johnson Veterans Affairs Medical Center, Charleston, SC, USA. Lipschut@musc.edu. |
| Source: | Npj metabolic health and disease [NPJ Metab Health Dis] 2026 Mar 25; Vol. 4 (1). Date of Electronic Publication: 2026 Mar 25. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Portfolio Country of Publication: England NLM ID: 9918751588706676 Publication Model: Electronic Cited Medium: Internet ISSN: 2948-2828 (Electronic) Linking ISSN: 29482828 NLM ISO Abbreviation: NPJ Metab Health Dis Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2948-2828 |
|---|---|
| DOI: | 10.1038/s44324-026-00108-2 |
